Abstract: This invention relates to a press molding method of a fiber product, at high pressure and high temperature, by means of a press pad device (2) and a stamp device (3,4), wherein said fiber product (1) comprises a bottom part (11) and an edge part (10), characterized by said stamp device (3,4) comprising two stamp members (3,4), wherein a first stamp member (3) forms at least said bottom part (11) and a second stamp member (4) forms said edge part (10), wherein also comprising a gasket member (5) applied to a bottom portion (33) of stamp device (3), wherein said gasket member (5) forms an inner part on top said bottom part (11) and a second stamp member (4) may form said edge part (10). This invention also relates to fiber press mould (2,3,4) and a fiber product (1).

Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1 and R1 have meanings as provided in the description.

Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.

Abstract: This invention relates to Production method for fiber based cellulose material products by means of converting a blank or web, wherein there is provided a production space (1) including a converting production unit (2) intermittently producing a shaped product (5B), a supply station (3) and a supply path (4), comprising the steps of: a. Providing a supply of unconverted blanks or a web (5) at said supply station (3) having a density below 0,5 kg/dm3 and a wet content below 20% weight. b. Feeding an unconverted portion (5A) of said unconverted blanks or a web along said supply path (4), c.

Abstract: The present invention relates to a multi-layer material for press molding, a delivery system and a resulting fiber product. Also, a method for recovery is disclosed.

Abstract: A method for a hot press forming apparatus and a hot press forming apparatus (102; 202) for forming a blank (104), the hot press forming apparatus (102; 202) comprising a first die (106; 206) and a second die (108), wherein the first die (106; 206) has at least one die cavity (110; 210), and the second die (108) has at least one die protrusion (112), wherein the hot press forming apparatus (102; 202) is configured to, by means of the first and second dies (106, 108; 206, 108), press form the blank (104) placed between the first and second dies (106, 108; 206, 108). At least one of the first and second dies (106, 108; 206, 108) has a draw radius (116; 216), wherein a member (118; 218) is attached to a die (106; 206) which has a draw radius (116; 216). At least a portion (119; 219) of the member (118; 218) is positioned adjacent to or on the draw radius (116; 216).

Abstract: A cold working apparatus for forming a blank includes a first die and a second die. The first die has at least one die cavity and the second die has at least one die protrusion. The cold working apparatus press forms the blank placed between the first and second dies.

Abstract: A fiber capsule and a method of compression molding a fiber-based packaging capsule, includes the steps: a raw capsule of a loosely bonded fiber mat is formed, which capsule has an opening; the raw capsule of the loosely bonded fiber mat is positioned on the inside of a substantially rigid mold having inner surfaces defining the molded outer surfaces of the fiber-based packaging capsule; the loosely bonded fiber mat is compression molded by the insertion of a pressurizable compression member through the opening. The pressing device is pressurized at a temperature of 150-250 degrees C.°. The compression molding takes place by reshaping the reshaping pressing device and pressing the inside of the capsule against the inner surfaces of the rigid mold so that a cohesive fiber-based packaging capsule is obtained.

Abstract: A fiber capsule and a method of compression molding a fiber-based packaging capsule, includes the steps: forming a raw capsule of a loosely bonded fiber mat, which capsule has an opening, positioning the raw capsule of the loosely bonded fiber mat on the inside of a substantially rigid mol having inner surfaces defining the molded outer surfaces of the fiber-based packaging capsule, compression molding the loosely bonded fiber mat by the insertion of a pressurizable compression member through the opening, and pressurizing the pressing device at a temperature of 150-250 degrees C.°, preferably 160-200 degrees C., and at a pressure of 100-5000 bar, preferably 300-1200 bar. The compression molding may take place by reshaping the reshaping pressing device and pressing the inside of the capsule against the inner surfaces of the rigid mold so that a cohesive fiber-based packaging capsule is obtained.

Abstract: The present disclosure generally relates to a method for providing a barrier coating on a hollow container (100) comprising molded pulp. The method comprises providing a polymeric powder coating onto the interior surface (105a) and at least a portion of the exterior surface of the container (100) prior to curing and/or melting the powder coatings. The present disclosure also relates to a hollow container (100) formed by the method.

Abstract: The present disclosure generally relates to a method for providing a non-uniform barrier coating on a hollow container (100) comprising molded pulp. The method comprises depositing a polymeric powder on the interior container surface in at least one predetermined portion (105a-d) of the hollow container and subsequently treating the container with heat or irradiation. The present disclosure also relates to a hollow container (100) comprising a non-uniform polymeric powder coating.

Abstract: There is herein provided a compound of formula I or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.

Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.

Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.

Abstract: A method for a hot press forming apparatus and a hot press forming apparatus (102; 202) for forming a blank (104), the hot press forming apparatus (102; 202) comprising a first die (106; 206) and a second die (108), wherein the first die (106; 206) has at least one die cavity (110; 210), and the second die (108) has at least one die protrusion (112), wherein the hot press forming apparatus (102; 202) is configured to, by means of the first and second dies (106, 108; 206, 108), press form the blank (104) placed between the first and second dies (106, 108; 206, 108). At least one of the first and second dies (106, 108; 206, 108) has a draw radius (116; 216), wherein a member (118; 218) is attached to a die (106; 206) which has a draw radius (116; 216). At least a portion (119; 219) of the member (118; 218) is positioned adjacent to or on the draw radius (116; 216).

Abstract: A cold working apparatus (102; 202) for forming a blank (104), the cold working apparatus (102; 202) comprising a first die (106; 206) and a second die (108), wherein the first die (106; 206) has at least one die cavity (110; 210), and the second die (108) has at least one die protrusion (112), wherein the cold working apparatus (102; 202) is configured to, by means of the first and second dies (106, 108; 206, 108), press form the blank (104) placed between the first and second dies (106, 108; 206, 108). At least one of the first and second dies (106, 108; 206, 108) has a draw radius (116; 216), wherein a member (118; 218) is attached to a die (106; 206) which has a draw radius (116; 216). At least a portion (119; 219) of the member (118; 218) is positioned adjacent to or on the draw radius (116; 216).

Abstract: There is herein provided a compound of formula I or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.

Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.

Abstract: There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.